在澳大利亚人群中外部验证EORTC-DeCOG列线图预测前哨淋巴结阳性黑色素瘤患者复发、远处转移和总死亡率
本研究在澳大利亚黑色素瘤研究所前瞻性数据库中外部验证EORTC-DeCOG列线图,纳入2003至2015年前哨淋巴结活检阳性患者352例。复发、远处转移和总死亡率列线图的C统计量分别为0.68、0.69和0.66。复发和远处转移预测性能与开发人群相似,但总死亡率列线图性能显著较差(C统计量0.66 vs 原始推导队列0.70),临床使用可能不太可靠。
要点
- 复发列线图外部验证C统计量为0.68
- 远处转移列线图外部验证C统计量为0.69
- 总死亡率列线图C统计量0.66,低于原始推导队列0.70
核心结论
- 列线图在预测复发和远处转移方面于MIA人群和开发人群表现相似,提示其稳健。
- 总死亡率列线图在MIA人群性能显著较差(C统计量0.66 vs 原始EORTC-DeCOG推导队列0.70),临床使用可能不太可靠。
研究设计与样本
- 外部验证研究,数据来自2003至2015年前哨淋巴结活检阳性的患者,提取自前瞻性维护的澳大利亚黑色素瘤研究所(MIA)研究数据库。
- 使用列线图托管平台(Evidencio)上的集成私人验证门户进行ROC曲线及C统计量、回归系数和决策曲线净获益分析。
- 完整数据可用于352例患者。
主要发现
- 复发列线图验证的C统计量为0.68。
- 远处转移列线图验证的C统计量为0.69。
- 总死亡率列线图验证的C统计量为0.66。
- 总死亡率列线图在MIA人群的C统计量0.66显著低于原始EORTC-DeCOG推导队列的0.70。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Calculating an accurate prognosis for melanoma patients who have a positive sentinel node (SN) biopsy is important both for them and for their treating doctors to guide decision-making, particularly when adjuvant systemic therapy is being considered. The recently published EORTC-DeCOG nomograms aim to provide this via an online portal that predicts 5-year rates for recurrence, distant metastasis and overall mortality. The present study provides external validation of these nomograms. METHODS/MATERIALS: De-identified data from patients with a positive SN biopsy between 2003 and 2015 were extracted from the prospectively maintained Melanoma Institute Australia (MIA) research database. ROC-curves with C-statistics, regression co-efficients and Decision Curve Net Benefit analyses were performed using the integrated private validation portal on the nomograms' hosting platform (Evidencio). RESULTS: Complete data were available for 352 patients. The respective C-statistics for recurrence, distant metastasis and overall mortality nomogram validations were 0.68, 0.69 and 0.66. CONCLUSION: The performance of the nomograms in predicting recurrence and distant metastasis was similar in the MIA and the development populations, suggesting that they are robust. However, the overall mortality nomogram performance was significantly poorer in the MIA population (C-statistic 0.66) than in the original EORTC-DeCOG derivation cohort (C-statistic 0.70) and may therefore be less reliable for clinical use.
引用
- Li AT, Law J, Ch'ng S, et al. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes. Eur J Cancer. 2023. PMID: 37263897. doi:10.1016/j.ejca.2023.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。